Salvage Brachytherapy and Hyperthermia for Recurrent H&N-tumours
The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.
Locally Recurrent Head and Neck Cancer
RADIATION: Brachytherapy|OTHER: Hyperthermia
Late side effects, Comparison late side effects to standard therapy, Effects are followed up to 5 years after therapy
Quality of life, Assessment of quality of life with EORTC questionnaires, up to 5 years after therapy|Rate of local recurrencies, Assessment of cumulative local recurrence rate, up to 5 years after therapy|Overall survival, Rate of Overall survival, up to 5 years after therapy
The aim of the present trial is to assess the prospective results of protocol-based interstitial pulsed-dose-rate (PDR) brachytherapy with interstitial hyperthermia (iHT) in a group of selected patients where salvage surgery with clear resection margins was not possible.